Sol Gel Technologies Ltd (SLGL) - Total Liabilities
Based on the latest financial reports, Sol Gel Technologies Ltd (SLGL) has total liabilities worth $7.14 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sol Gel Technologies Ltd - Total Liabilities Trend (2014–2025)
This chart illustrates how Sol Gel Technologies Ltd's total liabilities have evolved over time, based on quarterly financial data. See SLGL net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Sol Gel Technologies Ltd Competitors by Total Liabilities
The table below lists competitors of Sol Gel Technologies Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ZongTai Real Estate Development Co Ltd
TW:3056
|
Taiwan | NT$6.32 Billion |
|
Becamex Infrastructure Development JSC
VN:IJC
|
Vietnam | ₫2.28 Trillion |
|
centrotherm international AG
F:CTNK
|
Germany | €288.95 Million |
|
EBEST Investment & Securities Co. Ltd
KQ:078020
|
Korea | ₩9.51 Trillion |
|
ITHAX Acquisition Corp III Class A Ordinary Shares
NASDAQ:ITHA
|
USA | $43.54K |
|
Brogent Technologies
TWO:5263
|
Taiwan | NT$2.26 Billion |
|
Kimteks Poliuretan Sanayi ve Ticaret AS
IS:KMPUR
|
Turkey | TL8.27 Billion |
|
Zwack Unicum Likoripari es Kereskedelmi Nyrt.
BUD:ZWACK
|
Hungary | Ft9.95 Billion |
Liability Composition Analysis (2014–2025)
This chart breaks down Sol Gel Technologies Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SLGL stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.84 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sol Gel Technologies Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sol Gel Technologies Ltd (2014–2025)
The table below shows the annual total liabilities of Sol Gel Technologies Ltd from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $7.11 Million | +1.57% |
| 2024-12-31 | $7.00 Million | +5.31% |
| 2023-12-31 | $6.64 Million | +50.46% |
| 2022-12-31 | $4.42 Million | -67.52% |
| 2021-12-31 | $13.60 Million | +63.56% |
| 2020-12-31 | $8.31 Million | -5.93% |
| 2019-12-31 | $8.84 Million | +53.06% |
| 2018-12-31 | $5.77 Million | -91.51% |
| 2017-12-31 | $68.01 Million | +60.71% |
| 2016-12-31 | $42.32 Million | +114.16% |
| 2015-12-31 | $19.76 Million | +323.99% |
| 2014-12-31 | $4.66 Million | -- |
About Sol Gel Technologies Ltd
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treat… Read more